Corvus Pharmaceuticals, Inc. (CRVS)
10.53
-0.12
(-1.13%)
USD |
NASDAQ |
Oct 23, 16:00
10.50
-0.03
(-0.28%)
After-Hours: 20:00
Corvus Pharmaceuticals Market Cap : 885.79M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 885.79M |
| October 22, 2026 | 895.89M |
| October 21, 2026 | 845.42M |
| October 20, 2026 | 860.56M |
| October 19, 2026 | 811.77M |
| October 16, 2026 | 800.83M |
| October 15, 2026 | 828.59M |
| October 14, 2026 | 789.05M |
| October 13, 2026 | 791.58M |
| October 12, 2026 | 845.42M |
| October 09, 2026 | 884.95M |
| October 08, 2026 | 858.87M |
| October 07, 2026 | 875.70M |
| October 06, 2026 | 888.32M |
| October 05, 2026 | 903.46M |
| October 02, 2026 | 916.92M |
| October 01, 2026 | 919.44M |
| September 30, 2026 | 969.07M |
| September 29, 2026 | 989.26M |
| September 28, 2026 | 998.52M |
| September 25, 2026 | 977.48M |
| September 24, 2026 | 992.63M |
| September 23, 2026 | 1.055B |
| September 22, 2026 | 1.131B |
| September 21, 2026 | 1.045B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.057B |
| September 17, 2026 | 1.056B |
| September 16, 2026 | 1.029B |
| September 15, 2026 | 1.089B |
| September 14, 2026 | 1.103B |
| September 11, 2026 | 1.086B |
| September 10, 2026 | 1.089B |
| September 09, 2026 | 1.121B |
| September 08, 2026 | 1.172B |
| September 04, 2026 | 1.210B |
| September 03, 2026 | 1.232B |
| September 02, 2026 | 1.195B |
| September 01, 2026 | 1.200B |
| August 31, 2026 | 1.181B |
| August 28, 2026 | 1.191B |
| August 27, 2026 | 1.238B |
| August 26, 2026 | 1.239B |
| August 25, 2026 | 1.225B |
| August 24, 2026 | 1.185B |
| August 21, 2026 | 1.216B |
| August 20, 2026 | 1.205B |
| August 19, 2026 | 1.295B |
| August 18, 2026 | 1.248B |
| August 17, 2026 | 1.254B |
| August 14, 2026 | 1.253B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 3.931 |
| Price | 10.53 |
| Earnings Yield | -5.87% |